Sort
23,748 grants matching “melanoma”
Leveraging the Lymphocytic Infiltration of Soft Tissue Sarcoma for Autologous Cellular Immunotherapy
$245,296John Mullinax · H. Lee Moffitt Cancer Ctr & Res Inst · K08 · FY2022 · CA
Leveraging the Lymphocytic Infiltration of Soft Tissue Sarcoma for Autologous Cellular Immunotherapy
$245,296John Mullinax · H. Lee Moffitt Cancer Ctr & Res Inst · K08 · FY2020 · CA
Exploiting Lymphopenia to Augment the Adoptive Immunotherapy of Melanoma Patients
$245,258Bernard A Fox · Providence Portland Medical Center · R01 · FY2008 · CA
Exploiting Lymphopenia to Augment the Adoptive Immunotherapy of Melanoma Patients
$245,258Bernard A Fox · Providence Portland Medical Center · R01 · FY2007 · CA
Exploiting Lymphopenia to Augment the Adoptive Immunotherapy of Melanoma Patients
$245,258Bernard A Fox · Providence Portland Medical Center · R01 · FY2009 · CA
GENE THERAPY FOR HUMAN MALIGNANT MELANOMA
$245,250Introgen Therapeutics, Inc. · R41 · FY2002 · CA
Isolation of novel tumor antigens
$245,233Mirus Bio Corporation · R43 · FY2002 · CA
KiSS1 and Its G-Protein Coupled Receptor in Metastasis
$245,226Mingyao Liu · Texas A&M University Health Science Ctr · R01 · FY2007 · CA
KiSS1 and Its G-Protein Coupled Receptor in Metastasis
$245,226Mingyao Liu · Texas A&M University Health Science Ctr · R01 · FY2009 · CA
KiSS1 and Its G-Protein Coupled Receptor in Metastasis
$245,226Mingyao Liu · Texas A&M University Health Science Ctr · R01 · FY2008 · CA
Core 3-Biostatistics
$245,216J. Jack Lee · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
DCs Regulate Chemokine Responsiveness of Melanoma-Specific T Cells
$245,203Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P50 · FY2009 · CA
ADMINISTRATION
$245,187Antoni Ribas · University Of California Los Angeles · P01 · FY2014 · CA
Synthesis of Diazonamides
$245,100University Of Texas Austin · R01 · FY2002 · CA
Synthesis of Diazonamides
$245,100University Of Texas Austin · R01 · FY2003 · CA
Synthesis of Diazonamides
$245,100University Of Texas Austin · R01 · FY2004 · CA
Inhibitors of p53-S100B interaction for melanoma
$245,080Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Development of a novel pharmacologic strategy to activate normal pathways of differentiation in melanoma
$245,080Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Non-invasive detection of malaria parasites in vitro and in Cameroonian adults
$245,063Sunil Parikh · Yale University · R21 · FY2022 · AI
Project 2: Intratumoral PDT Induces PDP-based Enhancement of PD-1 Inhibition in Pancreatic Carcinoma
$245,034Vinay Chandrasekhara · Massachusetts General Hospital · P01 · FY2023 · CA
Regulatory T Cells and Toll-Like Receptor Signaling in Lymphoma Therapy
$244,900Wang Rongfu · Baylor College Of Medicine · P50 · FY2007 · CA
Administrative Core 1
$244,858Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Administrative Core 1
$244,854Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Anti-angiogenesis targeted vaccine therapy
$244,843Samir Khleif · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
GENETIC CONTROL OF CELL FATE DIVERSITY IN DROSOPHILA
$244,834Duke University · R01 · FY2003 · GM